The company, formerly known as Sichuan Hezong Pharmaceutical Co., Ltd., was initially funded by Li Yanfei, Tian Wenwen, and Li Jin on April 28, 2007. The company's traditional business mainly covers pharmaceutical wholesale, pharmaceutical B2B e-commerce, and pharmaceutical offline retail. The company's growth business is mainly focused on the new industrial sector. The main products and services include Western medicine, proprietary Chinese medicines, Chinese herbal medicines, food and health food, medical devices and non-pharmaceuticals, and other categories, commercial B2B e-commerce systems, commercial wholesale ERP systems, commercial SCRM systems, retail chain ERP systems, integrated retail platform systems, clinic HIS systems, and value-added services for the development and application of intelligent coding, intelligent storage, intelligent pricing, intelligent product selection, joint drug use, pharmaceutical services, etc. Corporate honors: In 2022, the company was selected as a national e-commerce model enterprise by the Ministry of Commerce of the People's Republic of China; the company was elected as the Secretary General of the MAH Branch of the China Pharmaceutical Finance Association; the company was rated as “Sichuan New Business Format and New Model Innovative Enterprise” by the Sichuan Provincial Department of Commerce, the Sichuan Provincial Development and Reform Commission, and the Sichuan Provincial Market Supervision Administration; the company was rated as “Top 100 Private Pharmaceutical Enterprises in Chengdu” by the Chengdu Federation of Enterprises Federation of Industry and Commerce and the Pharmaceutical Business Branch of the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce.
No Data